Mark Lennihan / AP

Pharmaceutical company and drug distributor executives made one thing clear this week: There's still no agreed-upon solution to lowering the costs of drugs, and that's given them the green light to continue operating under the status quo.

Drug pricing has been a burning political issue well before President Trump called out the industry, ignited by the likes of Martin Shkreli and Valeant Pharmaceuticals. Some companies, like Allergan, have pledged to limit price increases to less than 10%, no more than once per year. But those types of changes are in the minority, and many other drug makers continue to raise list prices that greatly exceed inflation — the latest example being a 552% increase over two years for a naloxone injector, according to Kaiser Health News.

Even the way a lot of pharmaceutical executives talk shows the issue hasn't really changed. Read on to see what some industry executives said during recent earnings conference calls about the pricing environment.

Drug manufacturers

  • Pfizer CEO Ian Read, who was not in this week's congregation of drug companies at the White House, tied lower drug prices to changes the Trump administration would have to make, such as looser Food and Drug Administration regulations and reduced corporate tax rates: "To the extent that they can remove regulations and make it easier and faster to bring drugs to market, that will make the marketplace a lot more competitive, which will then in turn help to bring down drug prices."
  • Eli Lilly CEO Dave Ricks: "I think we all understand the concern (Trump) is raising, and of course others are, that consumer out-of-pocket costs seem to be growing … We did not get into elaborate policy detail in terms of the U.S. pricing environment. But I think there will be time for that later."
  • Merck CEO Ken Frazier said Trump wants to "ease the cost burden on patients. But he was also quick to say he recognizes the importance of this industry, and he doesn't want to interfere with the incentives in the marketplace for us to continue to take risks."

Drug distribution companies

  • AmerisourceBergen CFO Tim Guttman said the company benefited from drug companies raising prices normally in January, and he still expects the usual price increases in June or July. However, there's less certainty about those summer price hikes: "This is clearly an open item given the unpredictability of pricing actions and the heightened level of scrutiny."
  • McKesson CFO James Beer said he has seen "mid to high single-digit brand manufacturer price inflation," and he senses that drug companies don't mind giving distributors their cut: "I think the manufacturers very much appreciate the work that we do and certainly have a willingness to fund our business model."

Go deeper

Ilhan Omar wins Minnesota primary

Photo: Stephen Maturen/Getty Images

Rep. Ilhan Omar (D-Minn.) won the Democratic primary against lawyer Antone Melton-Meaux on Tuesday evening, AP reports.

Why it matters: The race is one that's played out across the U.S. as progressives continue to sweep party nominations. Omar's win officially means all four progressive members of "The Squad" have won their primary elections.

Updated 3 hours ago - Politics & Policy

25 face felony charges after downtown Chicago hit by looters

Police officers inspect a damaged Best Buy in Chicago that was looted and vandalized. Photo: Scott Olson/Getty Images

Local police officers are seeking felony charges in 25 cases following the arrest of 100 people in the wake of widespread looting and property damage in Chicago on Monday, per the Washington Post.

Driving the news: Law enforcement said the event involving hundreds of people was a coordinated response after an officer shot a suspect Sunday evening, according to CBS Chicago.

Marjorie Taylor Greene wins Georgia's 14th district runoff

Photo: Elijah Nouvelage / Getty Images

Gun-rights activist Marjorie Taylor Greene defeated physician John Cowan in a runoff election for the Republican nomination in Georgia's deep-red 14th Congressional District on Tuesday, AP reports.

Why it matters: Greene, a vocal QAnon conspiracy theorist who has been condemned by GOP leaders for making multiple offensive remarks about Black people, Jews and Muslims in Facebook videos, is likely to win a seat in the House come November.